LIGAND PHARMACEUTICALS INC
CIK 886163 · last filed 2025-12-19
LIGAND PHARMACEUTICALS INC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for PTHS, was dated Dec 19, 2025. Across all open-market trades the lifetime net is −$7.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $142.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$142.18M
5
10
-$7.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | — | $26.90 | — | $0 | 2 | 2025-12-19 |
| VKTXW | 10%+ Owner | 5,819,383 | $4.60 | — | -$7.57M | 3 | 2020-08-28 |
| VKTX.W | 10%+ Owner | 6,300,964 | — | — | $0 | 1 | 2016-04-15 |
| VKTX | 10%+ Owner | 4,780,964 | $29.23 | $139.75M | $0 | 1 | 2015-06-01 |
| LGND | Director | 10,000 | $243.28 | $2.43M | $0 | 1 | 2008-08-06 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-19 | PTHS | Mixed | — | $0 | EDGAR |
| 2025-11-10 | PTHS | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | — | Mixed | +1,500,000 | $15.00M | |
| 2022-11-03 | — | Other (J) | −16,859,308 | $0 | |
| 2020-08-28 | VKTXW | Sell (S) | −148,700 | -$1.21M | EDGAR |
| 2020-08-27 | VKTXW | Sell (S) | −164,488 | -$1.33M | EDGAR |
| 2018-09-27 | VKTXW | Mixed | −262,881 | -$5.03M | EDGAR |
| 2016-04-15 | VKTX.W | Mixed | +1,520,000 | $1.20M | EDGAR |
| 2015-06-01 | VKTX | Other (J) | +228,105 | $0 | EDGAR |
| 2008-08-06 | LGND | Grant (A) | +10,000 | $0 | EDGAR |